Version Changes
Revised. Amendments from Version 1
The revised manuscript incorporates minor suggestions from the reviewers: a) Title has been changed b) Helices 5 and 6 now labelled in Fig1. c) References to recent work on antibodies cited (79 and 88).
Abstract
The dramatic transformation of the Zika virus (ZIKV) from a relatively unknown virus to a pathogen generating global-wide panic has exposed the dearth of detailed knowledge about this virus. Decades of research in the related Dengue virus (DENV), finally culminating in a vaccine registered for use in endemic regions (CYD-TDV) in three countries, provides key insights in developing strategies for tackling ZIKV, which has caused global panic to microcephaly and Guillain-Barre Syndrome. Dengue virus (DENV), a member of the family Flaviviridae, the causal agent of the self-limiting Dengue fever and the potentially fatal hemorrhagic fever/dengue shock syndrome, has been a scourge in tropical countries for many centuries. The recently solved structure of mature ZIKV (PDB ID:5IRE) has provided key insights into the structure of the envelope (E) and membrane (M) proteins, the primary target of neutralizing antibodies. The previously established MEPP methodology compares two conformations of the same protein and identifies residues with significant spatial and electrostatic perturbations. In the current work, MEPP analyzed the pre-and post-fusion DENV type 2 envelope (E) protein, and identified several known epitopes (His317, Tyr299, Glu26, Arg188, etc.) (MEPPitope). These residues are overwhelmingly conserved in ZIKV and all DENV serotypes, and also enumerates residue pairs that undergo significant polarity reversal. Characterization of α-helices in E-proteins show that α1 is not conserved in the sequence space of ZIKV and DENV. Furthermore, perturbation of α1 in the post-fusion DENV structure includes a known epitope Asp215, a residue absent in the pre-fusion α1. A cationic β-sheet in the GAG-binding domain that is stereochemically equivalent in ZIKV and all DENV serotypes is also highlighted due to a residue pair (Arg286-Arg288) that has a significant electrostatic polarity reversal upon fusion. Finally, two highly conserved residues (Thr32 and Thr40), with little emphasis in existing literature, are found to have significant electrostatic perturbation. Thus, a combination of different computational methods enable the rapid and rational detection of critical residues as epitopes in the search for an elusive therapy or vaccine that neutralizes multiple members of the Flaviviridae family. These secondary structures are conserved in the related Dengue virus (DENV), and possibly rationalize isolation techniques particle adsorption on magnetic beads coated with anionic polymers and anionic antiviral agents (viprolaxikine) for DENV. These amphipathic α-helices could enable design of molecules for inhibiting α-helix mediated protein-protein interactions. Finally, comparison of these secondary structures in proteins from related families illuminate subtle changes in the proteins that might render them ineffective to previously successful drugs and vaccines, which are difficult to identify by a simple sequence or structural alignment. Finally, conflicting results about residues that are involved in neutralizing a DENV-E protein by the potent antibody 5J7 (PDB ID:3J6U) are reported.
Keywords: Zika, Dengue, flaviviruses, microcephaly, Guillain-Barre Syndrome, envelope proteins, epitopes, neutralizing antibodies
Introduction
The genus Flavivirus of the family Flaviviridae comprises of more than 70 viruses, including important human pathogens such as the Zika (ZIKV), Dengue (DENV), Japanese encephalitis (JEV), yellow fever (YFV), Tick-borne encephalitis (TBEV) and West Nile (WNV) viruses 1, 2. Currently, only four flaviviruses (YFV, TBEV, JEV and DENV) have licensed vaccines 3, 4. In flaviviruses, a single polyprotein encoded by a positive-sense RNA genome is cleaved by viral and host proteases into three structural (premembrane:prM, envelope:E and core:C) and seven non-structural (NS1, NS2A, NS2B, NS3, NS4A, NS4B, and NS5) proteins 5. These Class II fusion viruses 6 enter the cell through clathrin-mediated endocytosis 7, 8, triggered by protonation of conserved histidine residues at low pH 9, 10. Conformational changes of E-homodimers to E-monomers at the viral surface expose a highly conserved fusion loop 11, which subsequently penetrates the outer leaflet of the host membrane 12, wherein a stable trimer creates a fusion pore allowing the nucleocapsid to enter the cytosol 13. Subsequent to viral replication, virus assembly creates nonfusogenic immature particles in the lumen of the endoplasmic reticulum. The host protease furin in the trans-Golgi network converts this non-virulent form to a smooth virulent virion by cleaving the globular prM into pr and M proteins, of which the M protein remains associated with meta-stable E homodimers 5, 14.
Until recently, ZIKV infections were rare and confined to Asia and Africa 15. An analysis of the 2007 ZIKV outbreak in Yap Island, Federated States of Micronesia concluded with the prophetic warning that ‘clinicians and public health officials should be aware of the risk of further expansion of Zika virus transmission’ 16. The dramatic transformation of this relatively unknown virus to a globally recognized pathogen occurred after it was detected in Brazil 17, and quickly spread across the globe (Brazil, France, United States of America, and El Salvador to- date), prompting a WHO emergency committee to assess the linkage of this virus to microcephaly and Guillain-Barré syndrome (GBS) 18, 19.
This sudden crisis has exposed the dearth of detailed knowledge about ZIKV. Computational homology modeling has been used to address this limitation exploiting the large volume of data available on related viral structures 20. While the genome of ZIKV was sequenced in 2007 21, the structure of mature ZIKV 22 was only recently determined, elucidating several salient features of the E and M proteins, the target of most neutralizing antibodies 23– 25. However, decades of research on other members of the Flavivirus family provides a trove of information that needs to be contextualized with respect to ZIKV.
DENV has four serotypes (DENV1-4) 26. The essential challenge in developing a tetravalent DENV vaccine has been the fact that antibodies for a particular serotype can be enhancing, and potentially life-threatening for secondary infections with other serotypes 27. Apart from vaccines, other anti-viral strategies include developing peptide vaccines 28, using peptide-inhibitors derived from the viral proteins 29, inhibiting the fusion process 30 and anionic peptides that target cationic ‘hotspots’ 31, 32. Computational epitope predictors like the sequence based RANKpep 33 or the structure based Pepitope 34 have been used to validate antibody binding 35, 36. A detailed structural analysis of proteins of these flaviviruses will provide deeper insight into conservation than a sequential analysis does. Furthermore, analyzing the spatial and electrostatic perturbations of protein structures after conformational changes arising due to the fusion process helps in identifying residues that are critical and possibly exposed to the environment, making them better candidates as vaccine epitopes.
In the current work, several computational methods were used to analyze DENV and ZIKV E protein structures. Firstly, a quantitative analysis of spatial and electrostatic perturbation in the pre 37 and post-fusion 12 DENV-2 E proteins was done using MEPP 38. This revealed that highly perturbed residues are overwhelmingly conserved, and also epitopes of known neutralizing antibodies 23, 35, 39– 43. Characterization of α-helices in E-proteins using techniques (PAGAL 44, 45) previously applied to the Ebola virus 46) revealed that α1 in ZIKV-E and DENV-E proteins is not conserved in the sequence space. Furthermore, α1 is perturbed in the post-fusion protein in DENV2-E protein 12, and includes a known epitope that is not part of the pre-fusion α1 41, 42, 47. PAGAL analysis also highlights a cationic β-sheet within a putative GAG-binding domain 48, 49, which consists of a pair of arginine residues that have significant electrostatic polarity reversal 48, 49. Finally, residues that are involved in antibody neutralizing by 5J7 were re-analyzed, and some conflicting results were obtained 50.
Methods
The MEPP (version 1) 38 and PAGAL (version 1) 44 packages have been previously described. The recently solved cryo-EM structure of ZIKV (PDB ID:5IRE) was used as the main structure for analysis of ZIKV in the current study 22. PDB ID:1OKEA was the structure of the DENV2-E protein used for analyzing domains I-III, which lacks the stem and transmembrane domains 37. The structure of post-fusion DENV2-E protein was obtained from PDB ID:1OK8A 12. Since the post-fusion DENV2-E protein did not have side-chains densities for residues 145-158, these residues were removed from the pre-fusion protein (PDB ID:1OKEA) in order to have an uniform comparison (see 1OKEAFIXED.pdb in Dataset1). This has the implicit assumption that this loop effects both pre-fusion and post-fusion proteins in the same manner. A radius of 6Å was used to identify interacting residues 38. The ‘distance perturbation index’ is computed by dividing the absolute distance deviation with the smaller of the distances.
For the stem and transmembrane domains, a DENV3 (PDB ID:3J6SA) structure was used. Since PDB ID:3J6SA has resolution of 6Å and no side-chain atoms, SWISS-MODEL 51 was used to generate the model of PDB ID:3J6SA using the ZIKV-E protein (PDB ID:5IREA) as the template (see 3J6SASWISSA.pdb in Dataset1). Hardware requirements are very modest - all results here are from a simple workstation (8GB ram) and runtimes were a few minutes at the most.
The APBS (v1.4) 52, 53 parameters were set as described previously in 54. APBS writes out the electrostatic potential in dimensionless units of kT/e where k is Boltzmann’s constant, T is the temperature in K and e is the charge of an electron. All protein structures were rendered by PyMOL(TM) Molecular Graphics System, Version 1.7.0.0. ( http://www.pymol.org/). α-helices and β-sheets were extracted using DSSP (version 2.2.1) 55. Protein structures have been superimposed using MUSTANG (mustang-3.2.1) 56. The color coding for the Edmundson wheel is as follows: all hydrophobic residues are colored red, while hydrophilic residues are colored in blue: dark blue for positively charged residues, medium blue for negatively charged residues and light blue for amides.
Multiple sequence alignment was done using MAFFT (v7.123b) 57, and figures generated using the ENDscript server 58. In order to obtain a multiple sequence alignment with a single representative of a stereochemical group (positive, negative, aromatic and non-polar residues) the following substitutions were done: E >D, R >K, S >T, W >F, Y >F, L >M, V >M, I >M, A >M. Gly (without a side chain) and Pro (with a cyclic side chain) were not substituted. His was also not substituted, due to its importance in pH sensing among flaviviruses 9, 10. PHYML (v3.0) was used to generate phylogenetic trees from alignments 59.
Results
README.txt contains a description of the files.
Copyright: © 2016 Chakraborty S
Data associated with the article are available under the terms of the Creative Commons Zero "No rights reserved" data waiver (CC0 1.0 Public domain dedication).
The focus of the study in the current paper is the ZIKV and DENV envelope (E) protein, a determinant of tropism and virulence 60. Unless explicitly specified, residue numbering is based on DENV2 (PDB ID:1OKEA), while secondary structures are numbered according to the ZIKV protein (PDB ID:5IREA). Each E-protein subunit is about 500 residues long in these flaviviruses. The soluble ectodomain has three distinct domains (I, II, III) - domain I and II are interlaced in the sequence space 61. These domains are followed by a stem region which contains two cationic amphipathic helices separated by a stretch of conserved sequences 62, 63, ending in an anchor region with two transmembrane helices ( Figure 1, Figure 2). Apart from a conserved glycosylation site (Asn153) present in all flaviviruses, DENV has an additional site for N-linked glycosylation (Asn67) which regulates interaction with the lectin DC-SIGN 64. The hydrophobic anchoring fusion loop (residues 98-109), which penetrates the outer bilayer leaflet of the host cell membrane to initiate cell entry 65, is highly conserved in all flaviviruses ( Figure 1, Figure 2).
Figure 1. The structure of the ZIKA-E protein (PDB ID:5IRE).
The E-proteins form a raft-like structure, in complex with the M-proteins (not shown here). Most common exposed residues are the highly conserved fusion loop (residues 98-109 in blue), the glycosylation site (Asn154 in ZIKV, in orange), and the GAG-binding domain which consists of a cationic β-sheet (in magenta). The stem region consists of cationic amphipathic helices α3 and α4 in the E proteins in red and green, respectively. The hydrophobic transmembrane helices α5 and α6 are in cyan.
Figure 2. Multiple sequence alignment (MSA) of envelope (E) proteins from ZIKA/DENV1-4/JEV/WNV.
The most prominent difference between the E protein from DENV and other viruses analyzed here is a missing stretch of amino acids near the Asn153 glycosylation site. This stretch is the possible reason for an incorrect alignment of the conserved glycosylation site (N-x-S/T) sequence in the MSA (both ClustalW and MAFFT has this issue). Also, DENV has an additional glycosylation site (Asn67) missing in other viruses. MSA was done using MAFFT 57, and the alignment of the secondary structures were done using ESPript 58.
Analysis of spatial and electrostatic perturbation in the post fusion DENV-E protein
The pre-(PDB ID:1OKE 37) and post-(PDB ID:1OK8 12) fusion conformations of DENV2 were used for MEPP analysis 38. The major difference in these proteins is a 33Å displacement of domain III, as previously noted 9, 13. Several metrics were used for identifying residues that undergo spatial, electrostatic and secondary structure perturbations. The first analysis computed pairs of residues that have a electrostatic potential difference (EPD) reversal (EPD-R) (> 150 units), were within 8 Å of each other in both conformations and had minimal distance perturbation (<4Å). Residues were marked as (i) completely conserved, (ii) stereochemically equivalent or (iii) not conversed. His317, the residue implicated in pH sensing 66, 67, switches electrostatic polarity with respect to Thr315 ( Table 1). Both His317 and Thr315 are conserved in ZIKV/DENV1-4/JEV/WNV ( Figure 2), and are known epitopes 23, 43. Another pair (Arg286-Arg288) with EPD-R are stereochemically equivalent in ZIKV/DENV1-4/JEV/WNV ( Figure 3), and lie on a putative GAG-binding domain preceding the DI/DIII linker 48, 49. Thr359, which is an epitope for the same MAb that binds Thr315 and His317 23, but is not conserved even among DENV serotypes, is another such residue which has EPD-R with Ser363 ( Figure 2). Thus, barring the pair Thr32-Thr40 ( Table 1), all residues that have an EPD-R with respect to a spatially proximal residue are known to be epitopes, even when not conserved across different viruses.
Figure 3. Multiple sequence alignment (MSA) of envelope (E) proteins from ZIKA/DENV1-4/JEV/WNV after substituting for stereochemical equivalence.
The following substitutions were done in the sequence space: E>D, R>K, S>T, W>F, Y>F, L>M, V>M, I>M, A>M in order to use a single amino acid for positive, negative, aromatic and non-polar residues. Gly (without a side chain) and Pro (with a cyclic side chain) were not substituted. His was also not substituted, due to its importance in pH sensing among flaviviruses 9, 10. These substitutions enable MAFFT to align the glycosylation site properly. Also, these show the stereochemical equivalence of the cationic residues β-21 in ZIKV (PDB ID:5IREA), which is part of the GAG-binding domain.
Table 1. Residue pairs with reversal in electrostatic potential difference (EPD) in the post-fusion DENV2 E-protein.
These pairs have minimal distance perturbation (<4 Å), significant reversal in EPD (> 150 units) and are within 8 Å in both conformations. For example, Arg286-Arg288, part of a cationic β-sheet and a putative GAG-binding domain, has an electrostatic perturbation without having any relative spatial displacement. F-: final value in post-fusion DENV-E protein (PDB ID:1OK8A), O-: original value in pre-fusion DENV-E protein (PDB ID:1OKEA). Conserved in ZIKV and all four DENV serotypes? - Y: yes, N: no, StCh: stereochemically equivalent. Distances in Å. See Methods section for units of potential.
| PDB ID:1OK8A | PDB ID:1OKEA | F-EPD | O-EPD | δEPD | F-DIST | O-DIST | δ-DIST | Conserved |
|---|---|---|---|---|---|---|---|---|
| ARG/286/NH1
THR/315/OG1 THR/40/OG1 |
ARG/288/NH1
HIS/317/ND1 THR/32/OG1 |
96.1
164.6 151.8 |
-68.5
-70.6 -134.7 |
164.6
235.2 286.5 |
5.6
4.1 5.3 |
5.7
4.6 7.7 |
-0.1
-0.5 -2.4 |
StCh:StCh
Y-Y Y-Y |
| THR/359/OG1 | SER/363/OG | 104.6 | -56.0 | 160.6 | 5.1 | 7.0 | -1.9 | N-N |
Next, normalized distance deviations (see Methods) highlight Phe11, Tyr299, Ser7, Arg9, Glu26, Arg188, Glu13 and Gln316 as residues with the largest spatial perturbations ( Figure 4a). Barring Ser7, all residues are completely conserved in ZIKV/DENV1-4 ( Figure 2). A N-terminal peptide (DENV3,4-12 VGVGNRDFV) that enhances immunogenicity for CD8+ T cells when expressed from modified vaccinia Ankara includes Phe11, Ser7 and Arg9 39. Arg9 and Glu13 are also epitopes of other antibodies 35. This particular study also showed that the N8R substitution DNA vaccine had a more neutralizing and protective effect than wild-type immunized sera, both in vitro and in vivo 35. Arg9 is part of a salt bridge with Glu368 which maintains the structure of the E-protein in the pre-fusion state 10, 66. Tyr299 is part of the epitope for the cross-reactive neutralizing MAb DENV1-E102 68. Arg188 is essential for infectivity, and is neutralized by DC4 Fab 40, while the monoclonal antibody DD18-5 recognized residue Glu26 in DENV4 35, a residue predicted by the Pepitope server 34. Thus, all spatially perturbed residues identified by MEPP are known epitopes.
Figure 4. Spatial and electrostatic perturbations in the post-fusion DENV2-E protein analyzed using MEPP.
MEPP analyzes the spatial and electrostatic potential difference (EPD) deviations of each residue with respect to other residues in close proximity (< 6Å). ( a) Distance deviation. Barring Ser7, all residues are completely conserved in ZIKV and DENV. All residues, barring Gln316, are known epitopes. Gln316 precedes the histidine residue responsible for initiating pH driven conformational changes during cell entry. ( b) Electrostatic perturbation. Several residues identified by electrostatic features do not have known references as epitopes in current literature. Thr32 and Thr40 are two such residues, which are conserved in these flaviviruses.
The following residues have significant cumulative EPD deviations ( >150 EPD units) with other residues within 6Å - Thr32, Thr40, Lys160, Lys247, Asp249, Arg288, Met297 and His317 ( Figure 4b). His317, Arg288, Thr32 and Thr40 have been discussed above. Several residues identified by this electrostatic feature do not have known references in current literature. Of these residues, Lys160 and Met297 are not conserved in ZIKV/DENV1-4, while Asp249 is conserved in DENV, but not in ZIKV ( Figure 2). However, Thr32 and Thr40 are two conserved residues ( Figure 2) with EPD deviations, leading to an EPD-R as described above ( Table 1).
Subsequently, analysis of α-helices in the pre- and post-fusion DENV2-E protein revealed α1 is slightly perturbed post fusion, increasing in length by one residue (Asp215) compared to the pre-fusion α1 ( Figure 5, Table 2). Asp215 is important for infectivity 42, a proven 41 and predicted 47 epitope, and a membranotropic region of the E protein (peptide 29) 69.
Figure 5. Major structural differences between ZIKV and DENV E-proteins.
ZIKV (PDB ID:5IREA) in cyan, DENV2 (PDB ID:1OKEA) in magenta are superimposed using MUSTANG 56. An extra loop is present in ZIKV/JEV/WNV ( Figure 3), and absent in DENV, near the glycosylation site. α1 in ZIKV (residues 192-195) and α1 in DENV2 (residues 210-214) are not conserved. α1 of DENV2 increases in length by one post-fusion, and includes the known epitope Asp215.
Table 2. Features of α-helices in envelope (E) proteins from DENV2 and ZIKV.
The soluble ectodomain has two α-helices - α1 and α2. α1 is perturbed in the post-fusion DENV2, increasing in length by one to include the known epitope Asp215. Moreover, α1 is not conserved in the sequence space of ZIKV-E. α2 remains conserved all E-proteins, even after fusion. α3/ α4 are amphipathic and cationic. The transmembrane helices ( α5/ α6) with no charged residues have a low hydrophobic moment. HM: Hydrophobic moment, RPNR: Relative proportion of positive residues among charged residues, Len: length of the α-helix, NCH: number of charged residues.
| PDB ID | Feature | AH | Start | End | Len | HM | RPNR | NCH |
|---|---|---|---|---|---|---|---|---|
| 1OK8A (DENV2:post-fusion) | Asp215+ |
α1
α2 |
210
257 |
215
263 |
6
7 |
2.2
2.1 |
0.5
0.5 |
2
2 |
| 1OKEA (DENV2:pre-fusion) | Asp215- |
α1
α2 |
210
257 |
214
263 |
5
7 |
1.9
2.1 |
1
0.5 |
1
2 |
|
5IREA (ZIKV:pre-fusion) |
Diff from DENV2
amphipathic cationic amphipathic cationic uncharged hydrophobic uncharged hydrophobic |
α1
α2 α3 α4 α5 α6 |
192
262 407 437 463 484 |
195
268 423 453 477 498 |
4
7 17 17 15 15 |
2.8
2.1 10.4 6 2.1 1.3 |
1
0.5 0.8 1 -1 -1 |
1
2 5 2 0 0 |
Analysis of secondary structures
The secondary structures from DENV and ZIKV E-proteins were extracted using DSSP 55, and analyzed using PAGAL 44. The ZIKV-E protein (PDB ID:5IREA, length=501 residues) has six α-helices and thirty β-sheets (see SSEinfo.zip in Dataset 1). The Edmundson wheels 70 for these α-helices in the stem region ( Table 2) shows their amphipathic cationic nature ( Figure 6). Interfacial hydrophobicity plays a critical role in cell entry of viruses 71. The membranotropic α3 and α4 in DENV4 69 has been studied extensively through mutational studies of the hydrophobic face 62, 63. Another strategy using peptide mimetic (residues 412 to 444, named DN59) derived from these helices showed inhibition of flaviviruses by releasing genomic RNA 72, 73. A similar study based on peptide mimetic of residues 419-447 (comprising the conserved stretch following α3 and α4) inhibited viral entry 74. These peptides were most effective at inhibition when three residues (442-444) were mutated to tryptophan, the most hydrophobic residue according to the Wimley-White whole residue hydrophobicity scale 75. An interesting feature of α4 is the complete conservation of residues on the charged surface - Ser439, Gly436, Lys432, Gly439 and H435 in DENV ( Figure 6), while the hydrophobic face is much more variable. Only Asn428 is not conserved ( Figure 2).
Figure 6. Edmundson wheel of the cationic amphipathic α-helices in the stem region of ZIKV-E (PDB ID:5IREA) and DENV3-E (PDB ID:3J6SA) proteins.
( a) α3 in DENV-E protein. ( b) α3 in ZIKV-E protein. ( c) α4 in DENV-E protein. ( d) α4 in ZIKV-E protein. The Edmundson wheel shows the amphipathic cationic nature of the stem helices. The hydrophobicity of residues in the hydrophobic face is an important determinant of virulence 63, 72, 73. The conservation of the charged face of α4 ( c and d) is in contrast to several differences in the hydrophobic face. The color coding for the Edmundson wheel is as follows: all hydrophobic residues are colored red, while hydrophilic residues are colored in blue: dark blue for positively charged residues, medium blue for negatively charged residues and light blue for amides.
ZIKV and DENV are Class II fusion viruses that deploy β-sheet-rich domains to destabilize membranes 6. The charged features of these β-sheets emphasizes β21 in ZIKV (294:KCRLK, preceding domain I/III linker) as distinctive, since it has three positively charged residues ( Figure 7a). Two arginine residues on this putative GAG-binding domain 48, 49, stereochemically equivalent in ZIKV/DENV1-4/JEV/WNV ( Figure 3), was identified by MEPP as having a significant electrostatic polarity reversal after membrane fusion ( Table 1). This residue pair (Arg286–Arg288) remains on the β-sheet post-fusion. This cationic ‘hotspot’ might be the target of small anti-viral anionic peptides 31, 32. A separate study focused on mutations in the DI/DIII linker demonstrated that a compensatory mutation in α3 (DENV-E Q400H) restored virus-like particle assembly disrupted by a mutation (DENV-E Y299F). Interestingly, DENV-E Q400 is not conversed even among DENV serotypes 76, and Tyr299 is distant from α3 ( Figure 7b).
Figure 7. Charged profile of β-sheets in the ZIKV-E protein (PDB ID:5IREA).
( a) β-21 in ZIKV-E is the most distinctive, and has three positively charged residues (290:KCRLK). The stereochemical nature of these residues are conserved in ZIKV/DENV1-4/JEV/WNV ( Figure 3). ( b) β21 is part of the GAG-binding domain that precedes the domain I/III linker, and is physically proximal to the cationic α4. This sheet has a pair (DENV:Arg286-Arg288) with electrostatic polarity reversal post-fusion. A mutation of Tyr299 to Phe299 disrupted virus-like particle assembly, although it was compensated by a mutation in α3 (DENV-E Q400H), which is distant from Tyr299.
Comparing E proteins in flaviviruses
The phylogenetic tree for these flaviviruses derived from the multiple sequence alignment (MSA) of the E-protein shows that TBEV and YFV are related, and distant from ZIKV/DENV1-4/JEV/WNV (see Supplementary material Figure 1). TBEV and YFV were excluded from the MSA. Excluding TBEV and YFV shows that ZIKV, JEV and WNV have a loop near the glycosylation site which is missing in DENV ( Figure 2). However, both ClustalW 77 and MAFFT 57) failed to align the glycosylation residues correctly. Replacing stereochemically equivalent residues (see Methods) corrected this alignment, and also gave a better visualization of conservation and differences ( Figure 3).
Conflicting data in comparison to previous studies
A recent study on the DENV3-specific human monoclonal antibody 5J7 demonstrated a very potent neutralizing effect through the binding of envelope proteins (PDB ID:3J6U) 50. Interacting residues were determined based on a distance of 8Å since side-chain densities were not resolved (cryo-EM Fab resolution was 9Å). Table 1 in the study reported that T35 from the heavy chain of 5J7 (PDB ID:3J6UH) interacts with four residues (Q52, Q131, E133, N134) from the DENV-E protein (PDB ID:3J6UC), and with K307 and K308 from another E-protein of the same complex. While T35 was within 10 Å for Q52, Q131, E133 and N134, the data on K307 and K308 could not be reproduced since T35 was found to be at a much larger distance from K308 in all three subunits (see Supplementary material Figure 2). The interacting residues of the heavy chain (PDB ID:3J6UH) and the light chain (PDB ID:3J6UL) with other subunits, as computed in this study (see Supplementary material Table 1 and Supplementary material Table 2, respectively). Distance-sorted interacting residues indicates Thr51 in the DENV3-E protein (chain C) is closest to the heavy chain (H-chain) ( Table 3). This explains the specificity of 5J7 to DENV3, since Thr51 is found only in DENV1 and DENV3. Another interacting residue, Thr223, is not conserved in any other DENV or ZIKV virus ( Figure 2). A different study using only the DENV3 domain III identified K307 and K308 as binding sites for mAb 14A4-8 in DENV3, but also included other domain III residues (K325, A329, G381 and I387) not present in 5J7 binding of DENV3 78. It was recently shown that a domain III-specific antibody protected mice from ZIKV infection 79.
Table 3. Interacting residues of the potent DENV antibody 5J7 (PDB ID:3J6U) with other subunits, sorted based on distance.
Thr51 in the DENV-3 protein (chain C) is closest to the Leu109 of the heavy chain (H-chain), and Thr223/Thr224 in the DENV-3 protein (chain C) is closest to Ile101 in the light chain (L-chain). Thr224 is conserved in ZIKV and the other DENV serotypes. However, Thr51 is conserved only in DENV1, while Thr223 is not conserved in ZIKV or other DENV serotypes, explaining the lack of neutralization of other serotypes by 5J7. The H-chain also binds to the conserved fusion loop of another DENV3-E protein (chain A).
| E
subunit |
Antibody | E atom | Antibody atom | Distance
Å |
|---|---|---|---|---|
| C
C C C C A C A A C |
H-chain
H-chain L-chain H-chain H-chain H-chain H-chain H-chain H-chain L-chain |
THR/51/CA
THR/51/CA THR/224/CA THR/51/CA GLN/52/CA GLY/104/CA LEU/53/CA GLY/106/CA GLY/106/CA THR/223/CA |
LEU/109/CA
GLU/108/CA ILE/101/CA LEU/110/CA GLU/108/CA ASN/63/CA LEU/110/CA SER/37/CA VAL/61/CA TYR/100/CA |
3.9
5.0 5.1 5.2 5.3 5.3 5.3 5.3 5.4 5.5 |
Limitations and conclusions
Spatial congruence of catalytic residues in the active site of functionally equivalent proteins, even with no sequence homology 80, has been long established 81. Further, electrostatic potential difference (EPD) 52, 53 was also shown to be conserved in cognate pairs of active site residues in these active sites 54, 82, 83. Comparison of apo and holo structures quantifying the spatial and electrostatic perturbations after ligand binding was shown to identify critical catalytic residues in several enzymes 38.
In the current work, this basic postulate was extended to posit that perturbed residues in viral envelope proteins during fusion with the host membrane are good candidates as epitopes for vaccines (MEPPitope). Specifically, computational methods 38, 44, 55 were used to analyze spatial, electrostatic and secondary structure perturbations between a pre- 37. and post-fusion 12 DENV2-E protein. These residues are overwhelmingly conserved in ZIKV and all DENV serotypes ( Figure 2), and are known epitopes 23, 35, 39– 43. While perturbation was found to be a good predictor of an epitope, not all epitopes are perturbed. For example, the current study did not identify any residues in the fusion loop, the target of several neutralizing antibodies 61, 84– 87, or Thr51/Thr224 ( Table 3) that is an epitope of a potent neutralizing antibody 50. The structure of ZIKV-E protein with the ligand 2A10G6, a flavivirus broadly neutralizing murine antibody, also reveals the fusion loop as an epitope 88. The hydrophobic fusion loop sequence is highly conserved in all flaviviruses ( Figure 2), demonstrating the importance of sequence alignment as a strategy to identify epitopes 89. The current study identified few perturbed residues in domain III (only His317 and Thr315) as significantly perturbed, consistent with the observation that although antibodies targeted to domain III endow protection and minimize enhancement when present, they are redundant and can be replaced by neutralizing antibodies targeted to other epitopes on the virion 90. This study indicates two residues (Thr32 and Thr40) as a significantly perturbed pair in terms of its electrostatic profile. Thr32 is conserved in all flaviviruses, while Thr40 in all conserved in all except TBEV, where it is the stereochemically equivalent Ser40. There has been no emphasis on these residues as epitopes in previous literature. In summary, the current study presents a computational methodology to extract structural and electrostatic features of envelope proteins that undergo conformational changes during fusion, which correlates well with known epitopes of DENV. Conservation of such residues in ZIKV provides a good strategy to leverage existing knowledge in developing ZIKV specific therapeutics.
Data availability
The data referenced by this article are under copyright with the following copyright statement: Copyright: © 2016 Chakraborty S
Data associated with the article are available under the terms of the Creative Commons Zero "No rights reserved" data waiver (CC0 1.0 Public domain dedication). http://creativecommons.org/publicdomain/zero/1.0/
F1000Research: Dataset 1. Raw data for ‘MEPPitope: spatial, electrostatic and secondary structure perturbations in the post-fusion Dengue virus envelope protein highlights known epitopes and conserved residues in the Zika virus’, 10.5256/f1000research.8853.d123549 91
Acknowledgements
I gratefully acknowledge Mridul Bhattacharjee and Nitin Salaye for logistic support. I would like to thank Ravindra Makde from High Pressure and Synchrotron Radiation Physics Division, Bhabha Atomic Research Centre, Mumbai, India for discussions on DENV structures.
Funding Statement
The author declared that no grants were involved in supporting this work.
[version 2; referees: 3 approved]
Supplementary material
Supplementary Figure 1. Phylogeny of different flaviviruses based on the E-protein sequence alignment.
Japanese encephalitis virus (JEV, GenBank Accid:AAZ17558.1), West Nile virus (WNV, GenBank Accid:ACH99530.1), Tick-borne encephalitis virus (TBEV, GenBank Accid:AEP25269.1), Yellow fever virus (YFV, GenBank Accid:AAA92696.1). TBEV and YFV are distantly related to DENV, ZIKV, JEV and WNV.
Supplementary Table 1. Interacting residues of the heavy chain (PDB ID:3J6UH) of the potent DENV antibody 5J7 with other subunits.
Interacting residues are identified as those with C α atoms within 8 Å of each other. The heavy chain binds to the A (PDB ID:3J6UA) and C (PDB ID:3J6UC) chains of the DENV-E protein, as well as the light chain (PDB ID:3J6UL).
| H-chain | DENV-E Chain A | DENV-E Chain C | L-chain |
|---|---|---|---|
| T35
S37 S38 Y39 T40 Q50 G51 L52 E53 W54 G56 G57 P60 V61 F62 N63 N66 Y67 A68 Y102 D106 K107 E108 L109 L110 F111 S112 R113 A114 F115 D116 W118 G119 Q120 G121 |
G106 G106 G106 C74 G104 C105 G106 S72 R73 C74 G104 C105 G106 G104 C105 |
Q52 E133 N134
Q52 L53 A54 Q131 Q52 L53 Q52 A54 Q52 T51 Q52 L53 A54 T51 Q52 L53 E49 A50 T51 Q52 L53 G273 T274 A50 T51 Q52 L53 A54 K128 V130 T274 T198 N270 G273 T274 |
Q107 G106 Q107 G108 Y94 F105 G106 Q107 T104 F105 P102 Y103 T104 F105 P102 I101 P102 P102 P102 P102 A50 Y39 Y56 G57 Y39 N41 Y56 G57 S98 Q99 N41 L53 Y56 G57 S98 L53 L53 A50 P51 A50 K49 A50 K49 A50 |
Supplementary Figure 2. Conflicting data on interacting residues of HMAb 5J7 and E-proteins (PDB ID:3J6U).
Side-chain densities were not resolved for cryo-EM Fab 5J7–DENV3 map since it had a 9 Å resolution. It is reported that ‘a slightly negatively charged patch formed by T35, S37, S82 and S84 of the heavy chain interacted with a positively charged patch formed by K307 and K308 of the E protein’, by considering interacting residues between Fab and E proteins where pairs of C α atoms are < 8 Å. However, the C α atoms of these residues are quite far. For example, T35 from 5J7 is 108, 51 and 78 Å away from K308 in the three E-proteins (PDB ID:3J6UA, 3J6UC and 3J6UE), respectively.
Supplementary Table 2. Interacting residues of the light chain (PDB ID:3J6UL) of the potent DENV antibody 5J7 with other subunits The C α atoms of interacting residues are within 8 Å of each other.
The C-chain of the DENV-E protein interacts with both the heavy and light chains.
| L-chain | DENV-E Chain C (3J6UC) | H-chain (3J6UH) |
|---|---|---|
| D8
S35 S37 Y39 N41 K49 A50 P51 L53 Y56 G57 S60 Y94 S98 Q99 Y100 I101 P102 Y103 T104 F105 G106 Q107 G108 |
E225
E123 E123 S271 G273 T223 T224 E225 A222 T223 T224 E225 T224 E225 |
S112 R113 R113 A114 Q120 G121 Y102 W118 G119 Q120 G121 W118 A114 F115 D116 S112 R113 A114 S112 R113 A114 L52 R113 A114 R113 G57 W54 G56 G57 N66 Y67 A68 W54 E53 W54 L52 E53 W54 G51 L52 Q50 G51 L52 G51 |
References
- 1. Kuno G, Chang GJ, Tsuchiya KR, et al. : Phylogeny of the genus Flavivirus. J Virol. 1998;72(1):73–83. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2. Mukhopadhyay S, Kuhn RJ, Rossmann MG: A structural perspective of the flavivirus life cycle. Nat Rev Microbiol. 2005;3(1):13–22. 10.1038/nrmicro1067 [DOI] [PubMed] [Google Scholar]
- 3. Guy B, Briand O, Lang J, et al. : Development of the Sanofi Pasteur tetravalent dengue vaccine: One more step forward. Vaccine. 2015;33(50):7100–7111. 10.1016/j.vaccine.2015.09.108 [DOI] [PubMed] [Google Scholar]
- 4. Shan C, Xie X, Barrett AD, et al. : Zika virus: Diagnosis, therapeutics, and vaccine. ACS Infect Dis. 2016;2(3):170–172. 10.1021/acsinfecdis.6b00030 [DOI] [PubMed] [Google Scholar]
- 5. Perera R, Kuhn RJ: Structural proteomics of dengue virus. Curr Opin Microbiol. 2008;11(4):369–377. 10.1016/j.mib.2008.06.004 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6. White JM, Delos SE, Brecher M, et al. : Structures and mechanisms of viral membrane fusion proteins: multiple variations on a common theme. Crit Rev Biochem Mol Biol. 2008;43(3):189–219. 10.1080/10409230802058320 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7. van der Schaar HM, Rust MJ, Chen C, et al. : Dissecting the cell entry pathway of dengue virus by single-particle tracking in living cells. PLoS Pathog. 2008;4(12):e1000244. 10.1371/journal.ppat.1000244 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8. Smit JM, Moesker B, Rodenhuis-Zybert I, et al. : Flavivirus cell entry and membrane fusion. Viruses. 2011;3(2):160–171. 10.3390/v3020160 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9. Mueller DS, Kampmann T, Yennamalli R, et al. : Histidine protonation and the activation of viral fusion proteins. Biochem Soc Trans. 2008;36(Pt 1):43–45. 10.1042/BST0360043 [DOI] [PubMed] [Google Scholar]
- 10. Kampmann T, Mueller DS, Mark AE, et al. : The role of histidine residues in low-pH-mediated viral membrane fusion. Structure. 2006;14(10):1481–1487. 10.1016/j.str.2006.07.011 [DOI] [PubMed] [Google Scholar]
- 11. Rockstroh A, Barzon L, Pacenti M, et al. : Recombinant envelope-proteins with mutations in the conserved fusion loop allow specific serological diagnosis of dengue-infections. PLoS Negl Trop Dis. 2015;9(11):e0004218. 10.1371/journal.pntd.0004218 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12. Modis Y, Ogata S, Clements D, et al. : Structure of the dengue virus envelope protein after membrane fusion. Nature. 2004;427(6972):313–319. 10.1038/nature02165 [DOI] [PubMed] [Google Scholar]
- 13. Bressanelli S, Stiasny K, Allison SL, et al. : Structure of a flavivirus envelope glycoprotein in its low-pH-induced membrane fusion conformation. EMBO J. 2004;23(4):728–738. 10.1038/sj.emboj.7600064 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14. Yu IM, Zhang W, Holdaway HA, et al. : Structure of the immature dengue virus at low pH primes proteolytic maturation. Science. 2008;319(5871):1834–1837. 10.1126/science.1153264 [DOI] [PubMed] [Google Scholar]
- 15. Hayes EB: Zika virus outside Africa. Emerg Infect Dis. 2009;15(9):1347–1350. 10.3201/eid1509.090442 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16. Duffy MR, Chen TH, Hancock WT, et al. : Zika virus outbreak on Yap Island, Federated States of Micronesia. N Engl J Med. 2009;360(24):2536–2543. 10.1056/NEJMoa0805715 [DOI] [PubMed] [Google Scholar]
- 17. Zanluca C, Melo VC, Mosimann AL, et al. : First report of autochthonous transmission of Zika virus in Brazil. Mem Inst Oswaldo Cruz. 2015;110(4):569–572. 10.1590/0074-02760150192 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18. Cao-Lormeau VM, Blake A, Mons S, et al. : Guillain-barré syndrome outbreak associated with Zika virus infection in French Polynesia: a case-control study. Lancet. 2016;387(10027):1531–1539. 10.1016/S0140-6736(16)00562-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19. Smith DW, Mackenzie J: Zika virus and Guillain-Barré syndrome: another viral cause to add to the list. Lancet. 2016;387(10027):1486–1488. 10.1016/S0140-6736(16)00564-X [DOI] [PubMed] [Google Scholar]
- 20. Ekins S, Liebler J, Neves BJ, et al. : Illustrating and homology modeling the proteins of the Zika virus [version 1; referees: 1 approved with reservations]. F1000Res. 2016;5:275 10.12688/f1000research.8213.1 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21. Kuno G, Chang GJ: Full-length sequencing and genomic characterization of Bagaza, Kedougou, and Zika viruses. Arch Virol. 2007;152(4):687–696. 10.1007/s00705-006-0903-z [DOI] [PubMed] [Google Scholar]
- 22. Sirohi D, Chen Z, Sun L, et al. : The 3.8 å resolution cryo-em structure of Zika virus. Science. 2016;352(6284):467–70. 10.1126/science.aaf5316 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23. Sukupolvi-Petty S, Austin SK, Purtha WE, et al. : Type- and subcomplex-specific neutralizing antibodies against domain iii of dengue virus type 2 envelope protein recognize adjacent epitopes. J Virol. 2007;81(23):12816–12826. 10.1128/JVI.00432-07 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24. Messer WB, de Alwis R, Yount BL, et al. : Dengue virus envelope protein domain i/ii hinge determines long-lived serotype-specific dengue immunity. Proc Natl Acad Sci U S A. 2014;111(5):1939–1944. 10.1073/pnas.1317350111 [DOI] [PMC free article] [PubMed] [Google Scholar] [Retracted]
- 25. Falconar AK: Identification of an epitope on the dengue virus membrane (M) protein defined by cross-protective monoclonal antibodies: design of an improved epitope sequence based on common determinants present in both envelope (E and M) proteins. Arch Virol. 1999;144(12):2313–2330. 10.1007/s007050050646 [DOI] [PubMed] [Google Scholar]
- 26. Yacoub S, Mongkolsapaya J, Screaton G: Recent advances in understanding dengue [version 1; referees: 3 approved]. F1000Res. 2016;5: pii: F1000 Faculty Rev-78. 10.12688/f1000research.6233.1 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27. Guzman MG, Vazquez S: The complexity of antibody-dependent enhancement of dengue virus infection. Viruses. 2010;2(12):2649–2662. 10.3390/v2122649 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28. Li W, Joshi MD, Singhania S, et al. : Peptide Vaccine: Progress and Challenges. Vaccines (Basel). 2014;2(3):515–536. 10.3390/vaccines2030515 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29. Schmidt AG, Yang PL, Harrison SC: Peptide inhibitors of dengue-virus entry target a late-stage fusion intermediate. PLoS Pathog. 2010;6(4):e1000851. 10.1371/journal.ppat.1000851 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30. De La Guardia C, Lleonart R: Progress in the identification of dengue virus entry/fusion inhibitors. Biomed Res Int. 2014;2014: 825039. 10.1155/2014/825039 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31. Laosutthipong C, Kanthong N, Flegel TW: Novel, anionic, antiviral septapeptides from mosquito cells also protect monkey cells against dengue virus. Antiviral Res. 2013;98(3):449–456. 10.1016/j.antiviral.2013.04.011 [DOI] [PubMed] [Google Scholar]
- 32. Alhoot MA, Rathinam AK, Wang SM, et al. : Inhibition of dengue virus entry into target cells using synthetic antiviral peptides. Int J Med Sci. 2013;10(6):719–729. 10.7150/ijms.5037 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33. Reche PA, Glutting JP, Zhang H, et al. : Enhancement to the rankpep resource for the prediction of peptide binding to MHC molecules using profiles. Immunogenetics. 2004;56(6):405–419. 10.1007/s00251-004-0709-7 [DOI] [PubMed] [Google Scholar]
- 34. Mayrose I, Penn O, Erez E, et al. : Pepitope: epitope mapping from affinity-selected peptides. Bioinformatics. 2007;23(23):3244–3246. 10.1093/bioinformatics/btm493 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35. Tang CT, Liao MY, Chiu CY, et al. : Generation of Monoclonal Antibodies Against Dengue Virus Type 4 and Identification of Enhancing Epitopes on Envelope Protein. PLoS One. 2015;10(8):e0136328. 10.1371/journal.pone.0136328 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36. Wen JS, Jiang LF, Zhou JM, et al. : Computational prediction and identification of dengue virus-specific CD4 + T-cell epitopes. Virus Res. 2008;132(1–2):42–48. 10.1016/j.virusres.2007.10.010 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37. Modis Y, Ogata S, Clements D, et al. : A ligand-binding pocket in the dengue virus envelope glycoprotein. Proc Natl Acad Sci U S A. 2003;100(12):6986–6991. 10.1073/pnas.0832193100 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38. Chakraborty S: A quantitative measure of electrostatic perturbation in holo and apo enzymes induced by structural changes. PLoS One. 2013;8(3):e59352. 10.1371/journal.pone.0059352 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39. Quinan BR, Flesch IE, Pinho TM, et al. : An intact signal peptide on dengue virus e protein enhances immunogenicity for CD8 + T cells and antibody when expressed from modified vaccinia ankara. Vaccine. 2014;32(25):2972–2979. 10.1016/j.vaccine.2014.03.093 [DOI] [PubMed] [Google Scholar]
- 40. Cox K, Tang A, Chen Z, et al. : Isolation of dengue neutralizing antibodies from single cell sorted human antigen specific memory b cell cultures (vac11p.1107). J Immunol. 2015;194(1 Supplement):212–15. Reference Source [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41. Lin HE, Tsai WY, Liu IJ, et al. : Analysis of epitopes on dengue virus envelope protein recognized by monoclonal antibodies and polyclonal human sera by a high throughput assay. PLoS Negl Trop Dis. 2012;6(1):e1447. 10.1371/journal.pntd.0001447 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42. Kroschewski H, Sagripanti JL, Davidson AD: Identification of amino acids in the dengue virus type 2 envelope glycoprotein critical to virus infectivity. J Gen Virol. 2009;90(Pt 10):2457–2461. 10.1099/vir.0.011486-0 [DOI] [PubMed] [Google Scholar]
- 43. Midgley CM, Flanagan A, Tran HB, et al. : Structural analysis of a dengue cross-reactive antibody complexed with envelope domain III reveals the molecular basis of cross-reactivity. J Immunol. 2012;188(10):4971–4979. 10.4049/jimmunol.1200227 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44. Chakraborty S, Rao B, Dandekar A: PAGAL - Properties and corresponding graphics of alpha helical structures in proteins [version 2; referees: 2 approved]. F1000Res. 2014;3:206. 10.12688/f1000research.4952.2 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45. Chakraborty S, Phu M, de Morais TP, et al. : The PDB database is a rich source of alpha-helical anti-microbial peptides to combat disease causing pathogens [version 2; referees: 2 approved, 1 approved with reservations]. F1000Res. 2014;3:295. 10.12688/f1000research.5802.2 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46. Chakraborty S, Rao B, Asgeirsson B, et al. : Characterizing alpha helical properties of Ebola viral proteins as potential targets for inhibition of alpha-helix mediated protein-protein interactions [version 3; referees: 2 approved]. F1000Res. 2014;3:251. 10.12688/f1000research.5573.3 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47. Mazumder R, Hu ZZ, Vinayaka CR, et al. : Computational analysis and identification of amino acid sites in dengue E proteins relevant to development of diagnostics and vaccines. Virus Genes. 2007;35(2):175–186. 10.1007/s11262-007-0103-2 [DOI] [PubMed] [Google Scholar]
- 48. Chen Y, Maguire T, Hileman RE, et al. : Dengue virus infectivity depends on envelope protein binding to target cell heparan sulfate. Nat Med. 1997;3(8):866–871. 10.1038/nm0897-866 [DOI] [PubMed] [Google Scholar]
- 49. Roehrig JT, Butrapet S, Liss NM, et al. : Mutation of the dengue virus type 2 envelope protein heparan sulfate binding sites or the domain III lateral ridge blocks replication in Vero cells prior to membrane fusion. Virology. 2013;441(2):114–125. 10.1016/j.virol.2013.03.011 [DOI] [PubMed] [Google Scholar]
- 50. Fibriansah G, Tan JL, Smith SA, et al. : A highly potent human antibody neutralizes dengue virus serotype 3 by binding across three surface proteins. Nat Commun. 2015;6: 6341. 10.1038/ncomms7341 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51. Arnold K, Bordoli L, Kopp J, et al. : The SWISS-MODEL workspace: a web-based environment for protein structure homology modelling. Bioinformatics. 2006;22(2):195–201. 10.1093/bioinformatics/bti770 [DOI] [PubMed] [Google Scholar]
- 52. Baker NA, Sept D, Joseph S, et al. : Electrostatics of nanosystems: application to microtubules and the ribosome. Proc Natl Acad Sci USA. 2001;98(18):10037–10041. 10.1073/pnas.181342398 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53. Dolinsky TJ, Nielsen JE, McCammon JA, et al. : PDB2PQR: an automated pipeline for the setup of Poisson-Boltzmann electrostatics calculations. Nucleic Acids Res. 2004;32(Web Server issue):W665–667. 10.1093/nar/gkh381 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54. Chakraborty S, Minda R, Salaye L, et al. : Active site detection by spatial conformity and electrostatic analysis--unravelling a proteolytic function in shrimp alkaline phosphatase. PLoS One. 2011;6(12):e28470. 10.1371/journal.pone.0028470 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 55. Joosten RP, te Beek TA, Krieger E, et al. : A series of PDB related databases for everyday needs. Nucleic Acids Res. 2011;39(Database issue):D411–419. 10.1093/nar/gkq1105 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 56. Konagurthu AS, Whisstock JC, Stuckey PJ, et al. : MUSTANG: a multiple structural alignment algorithm. Proteins. 2006;64(3):559–574. 10.1002/prot.20921 [DOI] [PubMed] [Google Scholar]
- 57. Katoh K, Standley DM: MAFFT multiple sequence alignment software version 7: improvements in performance and usability. Mol Biol Evol. 2013;30(4):772–780. 10.1093/molbev/mst010 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 58. Robert X, Gouet P: Deciphering key features in protein structures with the new ENDscript server. Nucleic Acids Res. 2014;42(Web Server issue):W320–W324. 10.1093/nar/gku316 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 59. Guindon S, Lethiec F, Duroux P, et al. : PHYML Online--a web server for fast maximum likelihood-based phylogenetic inference. Nucleic Acids Res. 2005;33(Web Server issue):W557–559. 10.1093/nar/gki352 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 60. Wan SW, Lin CF, Wang S, et al. : Current progress in dengue vaccines. J Biomed Sci. 2013;20(37):2–9. 10.1186/1423-0127-20-37 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 61. Dejnirattisai W, Wongwiwat W, Supasa S, et al. : A new class of highly potent, broadly neutralizing antibodies isolated from viremic patients infected with dengue virus. Nat Immunol. 2015;16(2):170–177. 10.1038/ni.3058 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 62. Lin SR, Zou G, Hsieh SC, et al. : The helical domains of the stem region of dengue virus envelope protein are involved in both virus assembly and entry. J Virol. 2011;85(10):5159–5171. 10.1128/JVI.02099-10 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 63. Purdy DE, Chang GJ: Secretion of noninfectious dengue virus-like particles and identification of amino acids in the stem region involved in intracellular retention of envelope protein. Virology. 2005;333(2):239–250. 10.1016/j.virol.2004.12.036 [DOI] [PubMed] [Google Scholar]
- 64. Mondotte JA, Lozach PY, Amara A, et al. : Essential role of dengue virus envelope protein N glycosylation at asparagine-67 during viral propagation. J Virol. 2007;81(13):7136–7148. 10.1128/JVI.00116-07 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 65. Nayak V, Dessau M, Kucera K, et al. : Crystal structure of dengue virus type 1 envelope protein in the postfusion conformation and its implications for membrane fusion. J Virol. 2009;83(9):4338–4344. 10.1128/JVI.02574-08 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 66. Prakash MK, Barducci A, Parrinello M: Probing the mechanism of pH-induced large-scale conformational changes in dengue virus envelope protein using atomistic simulations. Biophys J. 2010;99(2):588–594. 10.1016/j.bpj.2010.04.024 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 67. Chaudhury S, Ripoll DR, Wallqvist A: Structure-based pKa prediction provides a thermodynamic basis for the role of histidines in pH-induced conformational transitions in dengue virus. Biochem Biophys Rep. 2015;4:375–385. 10.1016/j.bbrep.2015.10.014 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 68. Shrestha B, Brien JD, Sukupolvi-Petty S, et al. : The development of therapeutic antibodies that neutralize homologous and heterologous genotypes of dengue virus type 1. PLoS Pathog. 2010;6(4):e1000823. 10.1371/journal.ppat.1000823 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 69. Nemésio H, Palomares-Jerez F, Villalaín J: The membrane-active regions of the dengue virus proteins C and E. Biochim Biophys Acta. 2011;1808(10):2390–2402. 10.1016/j.bbamem.2011.06.019 [DOI] [PubMed] [Google Scholar]
- 70. Schiffer M, Edmundson AB: Use of helical wheels to represent the structures of proteins and to identify segments with helical potential. Biophys J. 1967;7(2):121–135. 10.1016/S0006-3495(67)86579-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 71. Badani H, Garry RF, Wimley WC: Peptide entry inhibitors of enveloped viruses: the importance of interfacial hydrophobicity. Biochim Biophys Acta. 2014;1838(9):2180–2197. 10.1016/j.bbamem.2014.04.015 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 72. Lok SM, Costin JM, Hrobowski YM, et al. : Release of dengue virus genome induced by a peptide inhibitor. PLoS One. 2012;7(11):e50995. 10.1371/journal.pone.0050995 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 73. Hrobowski YM, Garry RF, Michael SF: Peptide inhibitors of dengue virus and West Nile virus infectivity. Virol J. 2005;2(1):49. 10.1186/1743-422X-2-49 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 74. Schmidt AG, Yang PL, Harrison SC: Peptide inhibitors of flavivirus entry derived from the E protein stem. J Virol. 2010;84(24):12549–12554. 10.1128/JVI.01440-10 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 75. White SH, Wimley WC: Membrane protein folding and stability: physical principles. Annu Rev Biophys Biomol Struct. 1999;28(1):319–365. 10.1146/annurev.biophys.28.1.319 [DOI] [PubMed] [Google Scholar]
- 76. de Wispelaere M, Yang PL: Mutagenesis of the DI/DIII linker in dengue virus envelope protein impairs viral particle assembly. J Virol. 2012;86(13):7072–7083. 10.1128/JVI.00224-12 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 77. Larkin MA, Blackshields G, Brown NP, et al. : Clustal W and Clustal X version 2.0. Bioinformatics. 2007;23(21):2947–2948. 10.1093/bioinformatics/btm404 [DOI] [PubMed] [Google Scholar]
- 78. Matsui K, Gromowski GD, Li L, et al. : Characterization of a dengue type-specific epitope on dengue 3 virus envelope protein domain III. J Gen Virol. 2010;91(Pt 9):2249–2253. 10.1099/vir.0.021220-0 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 79. Stettler K, Beltramello M, Espinosa DA, et al. : Specificity, cross-reactivity, and function of antibodies elicited by Zika virus infection. Science. 2016;353(6301):823–6. 10.1126/science.aaf8505 [DOI] [PubMed] [Google Scholar]
- 80. Rawlings ND, Barrett AJ: Evolutionary families of peptidases. Biochem J. 1993;290(Pt 1):205–218. 10.1042/bj2900205 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 81. Kleywegt GJ: Recognition of spatial motifs in protein structures. J Mol Biol. 1999;285(4):1887–1897. 10.1006/jmbi.1998.2393 [DOI] [PubMed] [Google Scholar]
- 82. Chakraborty S, Rao BJ: A measure of the promiscuity of proteins and characteristics of residues in the vicinity of the catalytic site that regulate promiscuity. PLoS One. 2012;7(2):e32011. 10.1371/journal.pone.0032011 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 83. Chakraborty S, Asgeirsson B, Minda R, et al. : Inhibition of a cold-active alkaline phosphatase by imipenem revealed by in silico modeling of metallo-β-lactamase active sites. FEBS Lett. 2012;586(20):3710–3715. 10.1016/j.febslet.2012.08.030 [DOI] [PubMed] [Google Scholar]
- 84. Smith SA, de Alwis AR, Kose N, et al. : The potent and broadly neutralizing human dengue virus-specific monoclonal antibody 1c19 reveals a unique cross-reactive epitope on the bc loop of domain ii of the envelope protein. MBio. 2013;4(6):e00873–13. 10.1128/mBio.00873-13 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 85. Lai CY, Tsai WY, Lin SR, et al. : Antibodies to envelope glycoprotein of dengue virus during the natural course of infection are predominantly cross-reactive and recognize epitopes containing highly conserved residues at the fusion loop of domain II. J Virol. 2008;82(13):6631–6643. 10.1128/JVI.00316-08 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 86. Cox KS, Tang A, Chen Z, et al. : Rapid isolation of dengue-neutralizing antibodies from single cell-sorted human antigen-specific memory B-cell cultures.In mAbs.number just-accepted, Taylor & Francis,2016;8(1):129–40. 10.1080/19420862.2015.1109757 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 87. Deng YQ, Dai JX, Ji GH, et al. : A broadly flavivirus cross-neutralizing monoclonal antibody that recognizes a novel epitope within the fusion loop of E protein. PLoS One. 2011;6(1):e16059. 10.1371/journal.pone.0016059 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 88. Dai L, Song J, Lu X, et al. : Structures of the Zika Virus Envelope Protein and Its Complex with a Flavivirus Broadly Protective Antibody. Cell Host Microbe. 2016;19(5):696–704. 10.1016/j.chom.2016.04.013 [DOI] [PubMed] [Google Scholar]
- 89. Leng CH, Liu SJ, Tsai JP, et al. : A novel dengue vaccine candidate that induces cross-neutralizing antibodies and memory immunity. Microbes Infect. 2009;11(2):288–295. 10.1016/j.micinf.2008.12.004 [DOI] [PubMed] [Google Scholar]
- 90. Williams KL, Wahala WM, Orozco S, et al. : Antibodies targeting dengue virus envelope domain III are not required for serotype-specific protection or prevention of enhancement in vivo. Virology. 2012;429(1):12–20. 10.1016/j.virol.2012.03.003 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 91. Chakraborty S: Dataset 1 in: MEPPitope: spatial, electrostatic and secondary structure perturbations in the post-fusion Dengue virus envelope protein highlights known epitopes and conserved residues in the Zika virus. F1000Research. 2016. Data Source [DOI] [PMC free article] [PubMed]









